TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024

GOSSELIES, Belgium--(BUSINESS WIRE)--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET) (Paris:ALVET), a pioneering company in the management of osteoarticular diseases in pets, today announces its Full-Year results for the year to December 31, 2023. The Company also informs its shareholders and the entire financial community of the availability of the preparatory documents for the Ordinary General Meeting of the Company to be held on June 6, 2024 at 5 p.m. (CEST) at Anderlecht, Bel